The Association Between VEGF +936C/T and −634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects

REFERENCES

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–249.
   PubMed Web of Science ®Google Scholar
• Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.
   PubMed Web of Science ®Google Scholar
• Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120–122.
   PubMed Web of Science ®Google Scholar
• King M-C, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643–646.
   PubMed Web of Science ®Google Scholar
• Joosse SA. BRCA1 and BRCA2: a common pathway of genome protection but different breast cancer subtypes. Nat Rev Cancer 2012;12:372.
   PubMedGoogle Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78–85.
   PubMed Web of Science ®Google Scholar
• Zhang D, Chen C, Fu X, Gu S, Mao Y, Xie Y, Huang Y, Li Y. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet 2008;53:18–33.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang D, Chen C, Mao Y, Xie Y, Li Y, Huang Y, Han B. TP53 Arg72Pro polymorphism and lung cancer risk: A meta-analysis. Int J Cancer 2009;125:2903–2911.
   PubMed Web of Science ®Google Scholar
• Zhang D, Chen C, Li Y, Fu X, Xie Y, Li Y, Huang Y. Cx31. 1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis. J Cell Mol Med 2012;16:1047–1059.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang D, Chen C, Ruan Z, Li Y, Huang Y. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 2012;23:1423–1434.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–676.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–395.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011;473:298–307.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 2002;52:331–339.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–676.
   PubMed Web of Science ®Google Scholar
• Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000;89:51–62.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–257.
   PubMed Web of Science ®Google Scholar
• Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature1993; 362(6423):841–4.
   Google Scholar
• Oliveira C, Lourenço GJ, Silva PMR, Cardoso-Filho C, Favarelli MHC, Gonçales NSL, Gurgel MSC, Lima CSP. Polymorphisms in the 5′-and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics. Tumor Biol 2011;32(2): 295–300.
   Google Scholar
• Liu L, Zeng F, Wang K, Huang J, Xin L, Zhu PQ. Meta-analysis of the association between VEGF-634 G> C and risk of malignancy based on 23 case–control studies. J Cancer Res Clin Oncol 2011; 32(2):295–300.
   Google Scholar
• Xu B, Li JM, Tong N, Tao J, Li PC, Song NH, Zhang W, Wu HF, Feng NH, Hua LX. VEGFA +936C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 2010;198: 7–14.
   PubMed Web of Science ®Google Scholar
• Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251–253.
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–826.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q, Ruan ZX, Gao YT, Zheng W. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005;65:5015–5019.
   PubMed Web of Science ®Google Scholar
• Knechtel G, Hofmann G, Gerger A, Renner W, Langsenlehner T, Szkandera J, Wolf G, Samonigg H, Krippl P, Langsenlehner U. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol 2010; 136(12):1813–1819.
   PubMedGoogle Scholar
• Lorenzen S, Panzram B, Keller G, Lordick F, Herrmann K, Becker K, Langer R, Schwaiger M, Siewert JR, Ott K. Association of the VEGF 936C> T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction. Mol Imag Biol 2011;13:178–186.
   PubMed Web of Science ®Google Scholar
• Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, Skaar T, Flockhart DA. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008;111:157–163.
   PubMed Web of Science ®Google Scholar
• Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106:468–471.
   PubMed Web of Science ®Google Scholar
• Smith KC, Bateman AC, Fussell HM, Howell WM. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 2004;31:167–173.
   PubMedGoogle Scholar
• Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Forsti A. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647–3653.
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006;8:R22–27.
   Google Scholar
• Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006;15:1148–1152.
   PubMed Web of Science ®Google Scholar
• Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007;121:1009–1016.
   PubMed Web of Science ®Google Scholar
• Langsenlehner U, Wolf G, Langsenlehner T, Gerger A, Hofmann G, Clar H, Wascher TC, Paulweber B, Samonigg H, Krippl P, Renner W. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian “tumor of breast tissue: incidence, genetics, and environmental risk factors” study. Breast Cancer Res Treat 2008;109:297–304.
   PubMed Web of Science ®Google Scholar
• Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szymanska-Pasternak J, Lener M, Narod SA, Lubinski J. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 2009;45:837–842.
   PubMed Web of Science ®Google Scholar
• Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, Tai MH, Cheng YH, Wen CH, Liu CS, Huang CJ, Wang CL, Chang HW. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 2009; 13(2):165–172.
   Web of Science ®Google Scholar
• Pharoah PDP, Tyrer J, Dunning AM, Easton DF, Ponder BAJ. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 2007;3:e42.
   PubMed Web of Science ®Google Scholar
• Eroğlu A, Öztürk A, Cam R, Akar N. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 2008;25:54–55.
   PubMed Web of Science ®Google Scholar
• Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. The VEGF_936_C> T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2008;262:71–76.
   PubMed Web of Science ®Google Scholar
• Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P. The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. Breast Cancer Res Treat 2012; 133(2): 769–778.
   PubMed Web of Science ®Google Scholar
• Luo T, Chen L, He P, Hu Q-C, Zhong X-R, Sun Y, Yang Y-F, Tian T-L, Zheng H. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population. Asian Pac J Cancer Prev 2013;14: 2433–2437.
   PubMed Web of Science ®Google Scholar
• Kapahi R, Manjari M, Sudan M, Uppal MS, Rajan N, Singh VS, Guleria K. Association of+ 405C> G and+ 936C> T polymorphisms of the vascular endothelial growth factor gene with sporadic breast cancer in North Indians. Asian Pac J Cancer Prev 2014;15:257–263.
   PubMed Web of Science ®Google Scholar
• Sa–Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, Kummalue T, Rojananin S, Ratanawichhitrasin A, Prasarttong–Osoth P, Chuthatisith S, Pisarnturakit P, Aeumrithaicharoenchok W. Vascular endothelial growth factor–634G/C polymorphism is associated with increased breast cancer risk and aggressiveness. Mol Med Rep 2013;8:1242–1250.
   PubMed Web of Science ®Google Scholar
• Gu D, Wang M. VEGF 936C> T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Res Treat 2011;125:489–493.
   PubMed Web of Science ®Google Scholar
• Yang DS, Park KH, Woo OH, Woo SU, Kim A-R, Lee ES, Lee J-B, Kim YH, Kim JS, Seo JH. Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011;125: 849–853.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu L, Zhu Z-M, Shao J-H, Xin L. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals. Cytokine 2011;56:167–173.
   PubMed Web of Science ®Google Scholar
• Carpini JD, Karam AK, Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 2010;13:43–58.
   PubMed Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37: 443–448.
   PubMed Web of Science ®Google Scholar
• Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. A common polymorphism in the 5’-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51: 1635–1639.
   PubMed Web of Science ®Google Scholar
• Sa-Nguanraksa D, Kooptiwut S, Chuangsuwanich T, Pongpruttipan T, Malasit P. Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer. Mol Med Rep 2014;9: 1044–1048.
   Web of Science ®Google Scholar